Quebec
Canada
16
2015-07-09
16
2016-01-26
These are the the leading inventors for applications assigned to Merck Canada Inc.:
Merck Canada Inc. based in Quebec, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pyrazolyl derivatives as Syk inhibitors
#2 | 2014-09-04 ✅ Patent 9,145,391 granted on 2015-09-29Bipyridylaminopyridines as Syk inhibitors
#3 | 2013-09-19 ✅ Patent 8,642,799 granted on 2014-02-04Cysteine protease inhibitors for the treatment of parasitic diseases
#4 | 2013-06-13 ✅ Patent 9,023,864 granted on 2015-05-05Indole derivatives as CRTH2 receptor antagonists
#5 | 2012-12-06 ✅ Patent 8,735,417 granted on 2014-05-27Aminopyrimidines as Syk inhibitors
#6 | 2012-11-01 ✅ Patent 8,759,366 granted on 2014-06-24Aminopyrimidines as SYK inhibitors
#7 | 2011-12-22 ✅ Patent 9,168,248 granted on 2015-10-27Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase
#8 | 2011-08-18 ✅ Patent 8,637,541 granted on 2014-01-28Indole derivatives as CRTH2 receptor antagonists
#9 | 2011-07-14 ✅ Patent 8,637,671 granted on 2014-01-28Indole derivatives as CRTH2 receptor antagonists
#10 | 2010-05-27 ✅ Patent 8,273,913 granted on 2012-09-25Amidation process for the preparation of cathepsin K inhibitors
#11 | 2010-04-29 ✅ Patent 8,003,661 granted on 2011-08-23Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists
#12 | 2010-02-25 ✅ Patent 8,518,964 granted on 2013-08-27Tricyclic compounds useful as inhibitors of kinases
#13 | 2009-04-16 ✅ Patent 8,013,159 granted on 2011-09-06Quinoline derivatives as EP4 antagonists
#14 | 2008-10-16 ✅ Patent 8,722,734 granted on 2014-05-13Composition for inhibition of cathepsin K
#15 | 2008-08-07 ✅ Patent 7,973,037 granted on 2011-07-05Cathepsin cysteine protease inhibitors
#16 | 2008-06-05 ✅ Patent 8,063,224 granted on 2011-11-22Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
441140 ⎘